Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, Drugs : A Statement for Healthcare Professionals From the Committee on Cardiovascular Monitoring of Children and Adolescents Receiving Psychotropic

[1]  B. Birmaher,et al.  Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[2]  M. Sanguinetti,et al.  Molecular Genetic Insights into Cardiovascular Disease , 1996, Science.

[3]  R. Thisted,et al.  Resolved: cardiac arrhythmias make desipramine an unacceptable choice in children. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[4]  R L Slaughter,et al.  Recent Advances: the Cytochrome P450 Enzymes , 1995, The Annals of pharmacotherapy.

[5]  N. Ryan,et al.  Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children. , 1995, The Journal of clinical psychiatry.

[6]  R. Baldessarini,et al.  Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.

[7]  S. Fletcher,et al.  Prospective study of the electrocardiographic effects of imipramine in children. , 1993, The Journal of pediatrics.

[8]  Y Chen,et al.  Mechanism of the cardiotoxic actions of terfenadine. , 1993, JAMA.

[9]  R. Baldessarini,et al.  A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

[10]  J. Schroeder,et al.  Cardiovascular effects of desipramine in children. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

[11]  D. Roden,et al.  Clinical features and basic mechanisms of quinidine-induced arrhythmias. , 1986, Journal of the American College of Cardiology.

[12]  C. Popper,et al.  Sudden Death Putatively Related to Desipramine Treatment in Youth: A Fifth Case and a Review of Speculative Mechanisms , 1995 .

[13]  K. Wagner,et al.  Potential mechanism of desipramine-related sudden death in children. , 1993, Psychosomatics.

[14]  D. Cohen,et al.  Sudden death in children receiving Norpramin: a review of three reported cases and commentary. , 1991, Journal of the American Academy of Child and Adolescent Psychiatry.

[15]  G. Elliott,et al.  Tricyclic Antidepressants: The QT Interval and Other Cardiovascular Parameters , 1990 .